| 摘要 |
Disclosed herein is the use of clodronic acid (dichloromethylenebisphosphonic acid), its addition salts or esters, hydrates of salts of hydrates as active ingredients for the preparation of a pharmaceutical in the form of an injectable solution or suspension for the treatment of podotrochlosis with associated osteoporosis in horses (navicular syndrome), the treatment being carried out by two to five intramuscular injections of the pharmaceutical within a period of up to approximately three consecutive days.
|
